| P50 | author | Giuseppe Giaccone | Q37829946 |
| P2093 | author name string | Paul van der Valk | |
| | Tanja D de Gruijl | |
| | Hester van Cruijsen | |
| | Mariëlle Gallegos Ruiz | |
| P2860 | cites work | Tumor angiogenesis: therapeutic implications | Q27860595 |
| | Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer | Q28278736 |
| | Cancer statistics, 2007 | Q29547293 |
| | The STATs of cancer--new molecular targets come of age | Q29614601 |
| | Tissue microarrays for high-throughput molecular profiling of tumor specimens | Q29618675 |
| | Immunosuppressive strategies that are mediated by tumor cells | Q29636247 |
| | Cancer vaccines: an update with special focus on ganglioside antigens | Q34522919 |
| | Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma | Q34570747 |
| | Role of tumor-associated gangliosides in cancer progression | Q35138120 |
| | Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer | Q35587652 |
| | Mechanisms and functional significance of tumour-induced dendritic-cell defects | Q35968465 |
| | In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. | Q36375533 |
| | Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis | Q38290076 |
| | Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells | Q38353138 |
| | Increased levels of gangliosides in the plasma and ascitic fluid of patients with advanced ovarian cancer. | Q40545055 |
| | Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine | Q40563512 |
| | Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells | Q40602668 |
| | Quantitative determination of N-glycolylneuraminic acid expression in human cancerous tissues and avian lymphoma cell lines as a tumor-associated sialic acid by gas chromatography-mass spectrometry. | Q41695236 |
| | Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas | Q44281294 |
| | Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis | Q44368619 |
| | Shed tumor gangliosides and progression of human neuroblastoma | Q46252789 |
| | Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer | Q46831080 |
| | Activation state EGFR and STAT-3 as prognostic markers in resected non-small cell lung cancer. | Q51773934 |
| | Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio | Q67803228 |
| | S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival | Q72379747 |
| | Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function | Q73482930 |
| | Angiogenic and Angiostatic Microenvironment in Tumors:Role of Gangliosides | Q73564466 |
| | Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer | Q73594867 |
| | A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors | Q74204147 |
| | Physiological concentrations of gangliosides GM1, GM2 and GM3 differentially modify basic-fibroblast-growth-factor-induced mitogenesis and the associated signalling pathway in endothelial cells | Q77983267 |
| | Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival | Q78107683 |
| | The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer | Q78508837 |
| | Gangliosides inhibit the development from monocytes to dendritic cells | Q78576588 |
| | Membrane ganglioside enrichment lowers the threshold for vascular endothelial cell angiogenic signaling | Q79322842 |
| | Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer: report of a phase I trial | Q79546792 |
| | 1E10 anti-idiotype vaccine in non-small cell lung cancer: experience in stage IIIb/IV patients | Q80186137 |
| | Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with (99m)Tc | Q81563612 |
| | Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization | Q81621780 |
| | Melanoma-derived gangliosides impair migratory and antigen-presenting function of human epidermal Langerhans cells and induce their apoptosis | Q83288986 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| | non-small-cell lung carcinoma | Q3658562 |
| | microvessel | Q6840468 |
| P304 | page(s) | 180 | |
| P577 | publication date | 2009-06-11 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer | |
| P478 | volume | 9 | |